Fenoglide launched for cholesterol treatment

Sciele Pharma has launched Fenoglide (fenofibrate) 40mg and 120mg tablets for the treatment of hyperlipidemia and hypertriglyceridemia. Fenoglide uses LifeCycle Pharma's MeltDose technology to provide enhanced absorption and greater bioavailability of fenofibrate.

For more information call (800) 849-9707 or visit www.sciele.com.